Diskussionsleiter: A. Skyschally (Essen)
| (P1868) | Der Orphan-Rezeptor GPRC5B beeinflusst hypertrophe Signalwege in Kardiomyozyten | |
| F. Stelter, G. Freundt, J. T. Nitz, N. Frey, H.-J. Hippe (Kiel) | ||
| (P1869) | Deletion of Nlrp3 protects from inflammation-induced skeletal muscle atrophy | |
| M. Kny, N. Huang, K. Busch, S. Schmidt, C. Butter, F. Riediger, F. C. Luft, H. Slevogt, J. Fielitz (Berlin, Bernau b. Berlin, Neuruppin, Jena) | ||
| (P1870) | Cancer-induced alterations in insulin signaling evoke cardiac metabolic changes and atrophy | |
| S. Pietzsch, B. Stapel, J. T. Thackeray, A. Haghikia, M. Ricke-Hoch, J. Heineke, G. M. Scharf, S. Erschow, F. Bengel, D. Hilfiker-Kleiner (Hannover) | ||
| (P1871) | Role of the redundant CaMKII isoforms δ and γ outside the heart – implications for future drug development | |
| J. Beckendorf, M. Kreußer, H. A. Katus, J. Backs (Heidelberg) |